Unkart Edward W 4
4 · KalVista Pharmaceuticals, Inc. · Filed Sep 28, 2023
Insider Transaction Report
Form 4
Unkart Edward W
Director
Transactions
- Award
Stock Option (right to buy)
2023-09-26+10,000→ 10,000 totalExercise: $10.08Exp: 2033-09-25→ Common Stock (10,000 underlying)
Footnotes (1)
- [F1]The option vests over a 12 month period: 1/12th on October 26, 2023, after which 1/12th of the total shares vest monthly, subject to continued service through each vesting date.